FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126005565> ?p ?o ?g. }

• W3126005565 endingPage "494" @default.
• W3126005565 startingPage "484" @default.
• W3126005565 abstract "Background: Drugs based on natural products targeting the microtubule system remain an important component in cancer therapy. Compound 10, 4-((3-amino-4-methoxyphenyl) amino)-2Hcoumarin, derived from coumarin, showed excellent anti-proliferative activity through directly binding to the colchicine-binding site in β-tubulin, suggesting that it could be a perfect drug candidate for antitumor drug research and development. Identification and structural characterization of metabolites is a critical step of both drug discovery and development research. Objective: Compound 10, 4-((3-amino-4-methoxyphenyl) amino)-2H-coumarin, derived from coumarin. Method: In this study, an efficient and sensitive method using Ultra High-Performance Liquid Chromatography couple with Quadrupole Time of Flight tandem Mass Spectrometry (UHPLC/QTOF/ MS/MS) was successfully established and applied to identify the in vivo metabolites in plasma, urine and feces samples of rats after intravenous administration of Compound 10 with a single dose of 10 mg/kg. Result: A total of eight metabolites (including two phase I and six phase II metabolites) had been detected or tentatively identified in plasma, urine and feces, indicating the prominent metabolic pathways were glucuronidation, demethylation and hydroxylation. In addition, in order to understand the structure of metabolites more accurately, synthesis strategy was used to confirm the metabolite M3. Conclusion: The present study provides important information on the metabolism of Compound 10 in vivo for the first time, which would be helpful for understanding the potential metabolic processes of Compound 10 and paving the way for pharmacology and toxicology research." @default.
• W3126005565 created "2021-02-01" @default.
• W3126005565 creator A5001490968 @default.
• W3126005565 creator A5002258631 @default.
• W3126005565 creator A5005636511 @default.
• W3126005565 creator A5029843517 @default.
• W3126005565 creator A5048966638 @default.
• W3126005565 creator A5052579232 @default.
• W3126005565 creator A5055435856 @default.
• W3126005565 creator A5072211626 @default.
• W3126005565 date "2021-04-01" @default.
• W3126005565 modified "2023-10-06" @default.
• W3126005565 title "Identification of In Vivo Metabolites of a Potential Anti-tumor Drug Candidate AMAC, in Rat Plasma, Urine and Feces Samples Using UHPLC/QTOF /MS/MS" @default.
• W3126005565 cites W1540615713 @default.
• W3126005565 cites W1918363244 @default.
• W3126005565 cites W1927137508 @default.
• W3126005565 cites W2011049230 @default.
• W3126005565 cites W2073588128 @default.
• W3126005565 cites W2102126947 @default.
• W3126005565 cites W2105906697 @default.
• W3126005565 cites W2121453280 @default.
• W3126005565 cites W2139240866 @default.
• W3126005565 cites W2164067249 @default.
• W3126005565 cites W2316679836 @default.
• W3126005565 cites W2322272262 @default.
• W3126005565 cites W2333560586 @default.
• W3126005565 cites W2398750638 @default.
• W3126005565 cites W2509940280 @default.
• W3126005565 cites W2549228264 @default.
• W3126005565 cites W2571683752 @default.
• W3126005565 cites W2591163633 @default.
• W3126005565 cites W2605741779 @default.
• W3126005565 cites W2611157898 @default.
• W3126005565 cites W2724511628 @default.
• W3126005565 cites W2743469499 @default.
• W3126005565 cites W2752490000 @default.
• W3126005565 cites W2770663839 @default.
• W3126005565 cites W2793171274 @default.
• W3126005565 cites W2797571813 @default.
• W3126005565 cites W2802588488 @default.
• W3126005565 doi "https://doi.org/10.2174/1573412916666191230124527" @default.
• W3126005565 hasPublicationYear "2021" @default.
• W3126005565 type Work @default.
• W3126005565 sameAs 3126005565 @default.
• W3126005565 citedByCount "0" @default.
• W3126005565 crossrefType "journal-article" @default.
• W3126005565 hasAuthorship W3126005565A5001490968 @default.
• W3126005565 hasAuthorship W3126005565A5002258631 @default.
• W3126005565 hasAuthorship W3126005565A5005636511 @default.
• W3126005565 hasAuthorship W3126005565A5029843517 @default.
• W3126005565 hasAuthorship W3126005565A5048966638 @default.
• W3126005565 hasAuthorship W3126005565A5052579232 @default.
• W3126005565 hasAuthorship W3126005565A5055435856 @default.
• W3126005565 hasAuthorship W3126005565A5072211626 @default.
• W3126005565 hasConcept C104317684 @default.
• W3126005565 hasConcept C112705442 @default.
• W3126005565 hasConcept C150194340 @default.
• W3126005565 hasConcept C150903083 @default.
• W3126005565 hasConcept C162356407 @default.
• W3126005565 hasConcept C178790620 @default.
• W3126005565 hasConcept C181199279 @default.
• W3126005565 hasConcept C185592680 @default.
• W3126005565 hasConcept C190727270 @default.
• W3126005565 hasConcept C192989942 @default.
• W3126005565 hasConcept C202199734 @default.
• W3126005565 hasConcept C202751555 @default.
• W3126005565 hasConcept C207001950 @default.
• W3126005565 hasConcept C2777477808 @default.
• W3126005565 hasConcept C2779907587 @default.
• W3126005565 hasConcept C2780026642 @default.
• W3126005565 hasConcept C2780035454 @default.
• W3126005565 hasConcept C2781109383 @default.
• W3126005565 hasConcept C2781338262 @default.
• W3126005565 hasConcept C31827203 @default.
• W3126005565 hasConcept C43617362 @default.
• W3126005565 hasConcept C55493867 @default.
• W3126005565 hasConcept C62231903 @default.
• W3126005565 hasConcept C81426234 @default.
• W3126005565 hasConcept C86803240 @default.
• W3126005565 hasConcept C87644729 @default.
• W3126005565 hasConcept C98274493 @default.
• W3126005565 hasConceptScore W3126005565C104317684 @default.
• W3126005565 hasConceptScore W3126005565C112705442 @default.
• W3126005565 hasConceptScore W3126005565C150194340 @default.
• W3126005565 hasConceptScore W3126005565C150903083 @default.
• W3126005565 hasConceptScore W3126005565C162356407 @default.
• W3126005565 hasConceptScore W3126005565C178790620 @default.
• W3126005565 hasConceptScore W3126005565C181199279 @default.
• W3126005565 hasConceptScore W3126005565C185592680 @default.
• W3126005565 hasConceptScore W3126005565C190727270 @default.
• W3126005565 hasConceptScore W3126005565C192989942 @default.
• W3126005565 hasConceptScore W3126005565C202199734 @default.
• W3126005565 hasConceptScore W3126005565C202751555 @default.
• W3126005565 hasConceptScore W3126005565C207001950 @default.
• W3126005565 hasConceptScore W3126005565C2777477808 @default.
• W3126005565 hasConceptScore W3126005565C2779907587 @default.
• W3126005565 hasConceptScore W3126005565C2780026642 @default.
• W3126005565 hasConceptScore W3126005565C2780035454 @default.

• next